FIXX Annual Cash & Cash Equivalents
$39.27 M
+$5.28 M+15.54%
01 December 2023
Summary:
As of January 21, 2025, FIXX annual cash & cash equivalents is $39.27 million, with the most recent change of +$5.28 million (+15.54%) on December 1, 2023. During the last 3 years, it has fallen by -$178.16 million (-81.94%).FIXX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX Quarterly Cash And Cash Equivalents
$39.27 M
+$10.15 M+34.88%
01 December 2023
Summary:
As of January 21, 2025, FIXX quarterly cash and cash equivalents is $39.27 million, with the most recent change of +$10.15 million (+34.88%) on December 1, 2023. Over the past year, it has increased by +$10.15 million (+34.88%).FIXX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.5% | +34.9% |
| 3 y3 years | -81.9% | +34.9% |
| 5 y5 years | +2.7% | +34.9% |
FIXX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -81.9% | -84.2% |
Homology Medicines Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $39.27 M(+15.5%) | $39.27 M(+34.9%) |
| Sept 2023 | - | $29.11 M(-62.1%) |
| June 2023 | - | $76.80 M(+94.6%) |
| Mar 2023 | - | $39.45 M(+16.1%) |
| Dec 2022 | $33.99 M(-68.6%) | $33.99 M(-21.3%) |
| Sept 2022 | - | $43.16 M(-75.5%) |
| June 2022 | - | $176.19 M(-29.0%) |
| Mar 2022 | - | $248.13 M(+128.9%) |
| Dec 2021 | $108.38 M(-50.2%) | $108.38 M(+13.1%) |
| Sept 2021 | - | $95.83 M(-17.6%) |
| June 2021 | - | $116.31 M(+11.4%) |
| Mar 2021 | - | $104.42 M(-52.0%) |
| Dec 2020 | $217.43 M | $217.43 M(+22.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $178.00 M(+6.2%) |
| June 2020 | - | $167.64 M(+16.9%) |
| Mar 2020 | - | $143.37 M(+166.6%) |
| Dec 2019 | $53.77 M(+40.7%) | $53.77 M(-30.7%) |
| Sept 2019 | - | $77.56 M(-32.9%) |
| June 2019 | - | $115.57 M(+183.0%) |
| Mar 2019 | - | $40.84 M(+6.9%) |
| Dec 2018 | $38.22 M(-25.9%) | $38.22 M(+6.1%) |
| Sept 2018 | - | $36.04 M(-62.0%) |
| June 2018 | - | $94.96 M(+105.5%) |
| Mar 2018 | - | $46.21 M(-10.4%) |
| Dec 2017 | $51.58 M(+352.7%) | $51.58 M |
| Dec 2016 | $11.39 M | - |
FAQ
- What is Homology Medicines annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Homology Medicines?
- What is Homology Medicines annual cash & cash equivalents year-on-year change?
- What is Homology Medicines quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Homology Medicines?
- What is Homology Medicines quarterly cash and cash equivalents year-on-year change?
What is Homology Medicines annual cash & cash equivalents?
The current annual cash & cash equivalents of FIXX is $39.27 M
What is the all time high annual cash & cash equivalents for Homology Medicines?
Homology Medicines all-time high annual cash & cash equivalents is $217.43 M
What is Homology Medicines annual cash & cash equivalents year-on-year change?
Over the past year, FIXX annual cash & cash equivalents has changed by +$5.28 M (+15.54%)
What is Homology Medicines quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of FIXX is $39.27 M
What is the all time high quarterly cash and cash equivalents for Homology Medicines?
Homology Medicines all-time high quarterly cash and cash equivalents is $248.13 M
What is Homology Medicines quarterly cash and cash equivalents year-on-year change?
Over the past year, FIXX quarterly cash and cash equivalents has changed by +$10.15 M (+34.88%)